Sniderman A - Search Results

1

ApoB versus non-HDL-cholesterol: diagnosis and cardiovascular risk management.

de Nijs T, Sniderman A, de Graaf J. de Nijs T, et al. Among authors: sniderman a. Crit Rev Clin Lab Sci. 2013 Nov;50(6):163-71. doi: 10.3109/10408363.2013.847897. Crit Rev Clin Lab Sci. 2013. PMID: 24295059 Review.

2

Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.

Barter PJ, Ballantyne CM, Carmena R, Castro Cabezas M, Chapman MJ, Couture P, de Graaf J, Durrington PN, Faergeman O, Frohlich J, Furberg CD, Gagne C, Haffner SM, Humphries SE, Jungner I, Krauss RM, Kwiterovich P, Marcovina S, Packard CJ, Pearson TA, Reddy KS, Rosenson R, Sarrafzadegan N, Sniderman AD, Stalenhoef AF, Stein E, Talmud PJ, Tonkin AM, Walldius G, Williams KM. Barter PJ, et al. Among authors: sniderman ad. J Intern Med. 2006 Mar;259(3):247-58. doi: 10.1111/j.1365-2796.2006.01616.x. J Intern Med. 2006. PMID: 16476102 Free article.

3

Effect of aging and obesity on the expression of dyslipidaemia in children from families with familial combined hyperlipidaemia.

ter Avest E, Sniderman AD, Bredie SJ, Wiegman A, Stalenhoef AF, de Graaf J. ter Avest E, et al. Among authors: sniderman ad. Clin Sci (Lond). 2007 Jan;112(2):131-9. doi: 10.1042/CS20060234. Clin Sci (Lond). 2007. PMID: 17054424

4

A diagnostic algorithm for the atherogenic apolipoprotein B dyslipoproteinemias.

de Graaf J, Couture P, Sniderman A. de Graaf J, et al. Among authors: sniderman a. Nat Clin Pract Endocrinol Metab. 2008 Nov;4(11):608-18. doi: 10.1038/ncpendmet0982. Epub 2008 Oct 7. Nat Clin Pract Endocrinol Metab. 2008. PMID: 18838971 Review.

5

Regulation of plasma LDL: the apoB paradigm.

Sniderman AD, De Graaf J, Couture P, Williams K, Kiss RS, Watts GF. Sniderman AD, et al. Clin Sci (Lond). 2009 Nov 23;118(5):333-9. doi: 10.1042/CS20090402. Print 2010 Mar. Clin Sci (Lond). 2009. PMID: 19922416 Free PMC article.

6

Diagnosis and treatment of apolipoprotein B dyslipoproteinemias.

Sniderman A, Couture P, de Graaf J. Sniderman A, et al. Nat Rev Endocrinol. 2010 Jun;6(6):335-46. doi: 10.1038/nrendo.2010.50. Epub 2010 Apr 27. Nat Rev Endocrinol. 2010. PMID: 20421882 Review.

7

Non-HDL C equals apolipoprotein B: except when it does not!

Sniderman A, Williams K, de Graaf J. Sniderman A, et al. Curr Opin Lipidol. 2010 Dec;21(6):518-24. doi: 10.1097/MOL.0b013e32833ee80c. Curr Opin Lipidol. 2010. PMID: 20827192 Review.

8

Application and validation of a diagnostic algorithm for the atherogenic apoB dyslipoproteinemias: ApoB dyslipoproteinemias in a Dutch population-based study.

Holewijn S, Sniderman AD, den Heijer M, Swinkels DW, Stalenhoef AF, de Graaf J. Holewijn S, et al. Eur J Clin Invest. 2011 Apr;41(4):423-33. doi: 10.1111/j.1365-2362.2010.02426.x. Epub 2010 Dec 3. Eur J Clin Invest. 2011. PMID: 21128932

9

A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk.

Sniderman AD, Williams K, Contois JH, Monroe HM, McQueen MJ, de Graaf J, Furberg CD. Sniderman AD, et al. Circ Cardiovasc Qual Outcomes. 2011 May;4(3):337-45. doi: 10.1161/CIRCOUTCOMES.110.959247. Epub 2011 Apr 12. Circ Cardiovasc Qual Outcomes. 2011. PMID: 21487090

10

Should preclinical vascular abnormalities be measured in asymptomatic adults to improve cardiovascular risk stratification?

de Graaf J, Holewijn S, Stalenhoef AF, Sniderman AD. de Graaf J, et al. Curr Opin Lipidol. 2011 Dec;22(6):454-9. doi: 10.1097/MOL.0b013e32834c6245. Curr Opin Lipidol. 2011. PMID: 21986644 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

402 results

Search Page

Filters